The past few weeks have brought a steady stream of positive developments for China's technology sector. At the turn of June and July, investors were already paying close attention to reports suggesting that Chinese artificial intelligence models are beginning to match their American counterparts in several key areas. Just days later, news emerged that DeepSeek is developing its own AI chip, another step toward reducing China's reliance on foreign technology suppliers. Now, another significant piece has been added to the puzzle. According to recent media reports, Apple has begun testing DRAM memory chips produced by Chinese manufacturer ChangXin Memory Technologies, better known as CXMT, which could eventually be used in devices sold in the Chinese market.

At this stage, the move does not mean Apple has signed a supply agreement or is preparing for mass production. Testing new components is a standard part of the supplier qualification process. Nevertheless, Apple's decision to evaluate technology developed by a Chinese memory manufacturer carries symbolic importance. Just a few years ago, CXMT was widely viewed as a company striving to catch up with the world's leading memory producers. Today, its products are being assessed by one of the world's largest consumer electronics companies.
This development is far from accidental. The global DRAM market has long been dominated by Samsung, SK Hynix, and Micron, making it exceptionally difficult for new entrants to secure a place in the global supply chain. Success requires not only advanced manufacturing capabilities but also the ability to meet strict standards for quality, reliability, and performance. Apple's testing suggests that Chinese memory manufacturers are gradually closing the technological gap with the industry's established leaders.
The timing is also significant. As artificial intelligence continues to expand, semiconductor memory has become one of the most critical components powering modern smartphones, data centers, and AI infrastructure. As a result, semiconductors have once again become a central battleground in the technological competition between the United States and China.

This is precisely why Beijing has spent years investing not only in domestic processors but also in memory chips, software, and every other component needed to build a self sufficient technology ecosystem. Reports about CXMT fit neatly into this broader strategy. DeepSeek is developing its own AI accelerator, Huawei continues expanding its Ascend processor lineup, and an increasing number of Chinese companies are replacing foreign technologies with domestic alternatives. Together, these efforts are aimed at reducing dependence on overseas suppliers while strengthening China's resilience against U.S. export controls and technology sanctions.
Apple has not confirmed that CXMT's memory chips will be used in commercial products, and the company may still be a long way from becoming an official supplier. Even so, the decision to begin testing is significant in itself. It suggests that Chinese semiconductor companies are no longer viewed solely as domestic alternatives but are increasingly emerging as credible participants in the global semiconductor industry. If this trend continues, it could become one of the most important shifts shaping the future of the global technology sector.

Source: xStation5
Alibaba shares surge 10% 🔼 Is capital coming back to China?
Oil price surge on US/Iran
Market wrap: European stocks slide amid renewed US - Iran conflict
Uranium stocks after the selloff 📉 Uranium Energy Corp. tumbles 50% from its highs
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.